PINNACLE ASSOCIATES LTD - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 139 filers reported holding ARRAY BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 3.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$38,804,000
-10.6%
837,563
-52.9%
0.91%
-7.2%
Q1 2019$43,394,000
+66.3%
1,779,884
-2.8%
0.98%
+45.4%
Q4 2018$26,094,000
-10.9%
1,831,159
-5.0%
0.67%
+10.9%
Q3 2018$29,299,000
-21.3%
1,927,536
-13.1%
0.61%
-20.6%
Q2 2018$37,235,000
-12.2%
2,219,024
-14.6%
0.77%
-7.8%
Q1 2018$42,413,000
+22.0%
2,598,828
-4.3%
0.83%
+24.4%
Q4 2017$34,777,000
-4.7%
2,716,983
-8.5%
0.67%
-0.7%
Q3 2017$36,508,000
+42.9%
2,968,108
-2.8%
0.67%
+37.1%
Q2 2017$25,549,000
-6.7%
3,052,448
-0.4%
0.49%
-6.1%
Q1 2017$27,388,000
-2.9%
3,063,577
-4.5%
0.52%
-8.1%
Q4 2016$28,212,000
+23.1%
3,209,507
-5.5%
0.57%
+23.7%
Q3 2016$22,915,000
+84.2%
3,394,817
-2.8%
0.46%
+71.6%
Q2 2016$12,439,000
+19.8%
3,494,127
-0.7%
0.27%
+20.7%
Q1 2016$10,382,000
-28.8%
3,519,267
+1.9%
0.22%
-27.5%
Q4 2015$14,574,000
-13.9%
3,453,487
-6.9%
0.31%
-18.2%
Q3 2015$16,920,000
-38.6%
3,710,420
-2.9%
0.37%
-26.8%
Q2 2015$27,543,000
-5.3%
3,820,053
-3.2%
0.51%
-5.9%
Q1 2015$29,086,000
+56.6%
3,946,483
+0.5%
0.54%
+49.2%
Q4 2014$18,575,000
+39.5%
3,926,968
+5.3%
0.36%
+34.3%
Q3 2014$13,313,000
+12.3%
3,729,223
+43.4%
0.27%
+17.3%
Q2 2014$11,856,000
-11.5%
2,599,933
-8.8%
0.23%
-11.5%
Q1 2014$13,395,000
-9.4%
2,850,023
-3.4%
0.26%
-9.7%
Q4 2013$14,781,000
+2.0%
2,950,263
+26.6%
0.29%
-3.7%
Q3 2013$14,497,0002,330,7800.30%
Other shareholders

There were no reported owners of ARRAY BIOPHARMA INC in Q4 2013.

NameSharesValueWeighting ↓
View complete list of ARRAY BIOPHARMA INC shareholders